Title:
USES OF MOGROL DERIVATIVE MONOMER AND COMPOSITION THEREOF
Document Type and Number:
WIPO Patent Application WO/2017/190420
Kind Code:
A1
Abstract:
A mogrol derivative monomer (4) having broad spectrum antitumor efficacy; the monomer is superior in terms of both activity and efficacy than structurally similar and commercially available antitumor medicament/healthcare product Rg3, also has greater efficacy than broad spectrum anticancer medicament paclitaxel, can be prepared into a medicament for use in treating and/or preventing different cancers and/or tumors and a healthcare product for use in immunomodulation and/or improving microcirculation and/or increasing the quality of life, is mainly applicable in treating malignant tumors, and has broad application prospects.
More Like This:
Inventors:
YU PEIHUA (CN)
DENG YUEMIN (CN)
ZHONG MUYUAN (CN)
DENG YUEMIN (CN)
ZHONG MUYUAN (CN)
Application Number:
PCT/CN2016/089203
Publication Date:
November 09, 2017
Filing Date:
July 07, 2016
Export Citation:
Assignee:
SHENZHEN ENOCH PHYTOMEDICINE CO LTD (CN)
International Classes:
C07J9/00; A61K31/575; A61P35/00; A61P35/02; A61P37/02
Domestic Patent References:
| WO2014107740A2 | 2014-07-10 | |||
| WO2015061686A2 | 2015-04-30 |
Foreign References:
| CN105832748A | 2016-08-10 | |||
| CN105777837A | 2016-07-20 | |||
| US20070032464A1 | 2007-02-08 | |||
| CN102482315A | 2012-05-30 |
Other References:
CHEN, XUBING ET AL.: "Potential AMPK Activators of Cucurbitane Triterpenoids from Siraitia Grosvenorii Swingle", BIOORGANIC & MEDICINAL CHEMISTRY, vol. 19, no. 19, 22 August 2011 (2011-08-22), pages 5776 - 5781, XP028294118, ISSN: 0968-0896, DOI: doi:10.1016/j.bmc.2011.08.030
Attorney, Agent or Firm:
SHENZHEN DEJIN INTELLECTUAL PROPERTY AGENCY CO., LTD. (CN)
Download PDF:
Previous Patent: USES OF MOGROL DERIVATIVE MONOMER AND COMPOSITION THEREOF
Next Patent: NOVEL MOGROL DERIVATIVE MONOMER
Next Patent: NOVEL MOGROL DERIVATIVE MONOMER